September 01, 2016 12:58 AM ET

Pharmaceuticals

Company Overview of Hydra Biosciences, Inc.

Key Executives for Hydra Biosciences, Inc.

NameBoard RelationshipsTitleAge
Russell H. Herndon 24 RelationshipsChief Executive Officer, President and Director57
David E. Clapham M.D., Ph.D.27 RelationshipsScientific Co-Founder, Chair of Scientific Advisory Board and Member of Pain Medical Advisory Board--
Mark T. Keating M.D.13 RelationshipsScientific Co-Founder and Member of Scientific Advisory Board - Cardiac Regeneration--
Thomas Joseph Burke No RelationshipsChief Financial Officer and Treasurer--
Bertrand L. Chenard Ph.D.No RelationshipsSenior Vice President of Chemistry, Pharmacology and Preclinical Development60
View More Key Executives

Hydra Biosciences, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert J. Carpenter 87 RelationshipsREC, Inc.70
Russell H. Herndon 24 RelationshipsHydra Biosciences, Inc.57
Mark T. Keating M.D. 13 RelationshipsHydra Biosciences, Inc.--
David E. Clapham M.D., Ph.D. 27 RelationshipsHydra Biosciences, Inc.--
Michael Sanguinetti Ph.D. 19 RelationshipsHydra Biosciences, Inc.--
View All Board Members

Hydra Biosciences, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.David E. Clapham27 Relationships9 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
430.2K
Bonus
547.0K
Total Short Term Compensation
638.1K
Total Value of Options
14.6M
Compensation as of Fiscal Year
Hydra Biosciences, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Sagent Pharmaceuticals, Inc. Announces Cessation of Board of Directors
August 29, 2016 8:17 PM ET
Nabriva Therapeutics AG Announces Executive Appointments
August 29, 2016 2:09 PM ET
Innovus Pharmaceuticals, Inc. Announces Executive Changes, Effective September 6, 2016
August 29, 2016 10:01 AM ET
Novogen Ltd. Announces Executive Changes
August 29, 2016 12:28 AM ET
Abbot Laboatories (Pakistan) Ltd. Announces Change in Director
August 29, 2016 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Hydra Biosciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.